Novo Nordisk, a Danish pharmaceutical company, lowered its full-year sales and profit guidance due to weaker growth expectations for its obesity drug, Wegovy, in the U.S. market. Shares dropped by 15% following the announcement. The company cited slower-than-expected market expansion and competition as reasons for the revised forecast.

Read more at CNBC

1. Apple announced a new initiative to combat climate change by investing $200 million in forestry projects. The tech giant aims to remove carbon emissions from the atmosphere to achieve a net-zero impact by 2030.

2. Tesla reported record-breaking vehicle deliveries in the third quarter, exceeding expectations with 241,300 cars delivered. The electric car company’s strong performance was driven by high demand for its Model 3 and Model Y vehicles.

3. The Federal Reserve is expected to start reducing its monthly bond purchases in November, according to a CNBC survey of economists. The move is seen as a step towards normalizing monetary policy after unprecedented support during the pandemic.: Novo Nordisk shares plunge after Wegovy-maker cuts full-year guidance